News | August 02, 2007

MEDecision Receives Recognition from Department of Commerce

August 3, 2007 — MEDecision Inc., a provider of software, services and clinical content to healthcare payers, received a "Recognition of Excellence in Innovation Certificate" from the United States Department of Commerce, which honors local and regional innovators nationwide who have introduced a new product or service into the market, utilized a new manufacturing process, or received a patent from the U.S. Patent and Trademark Office.

MEDecision received the honor for its Patient Clinical Summary (PCS), a clinically validated, payer-based electronic health record that compiles an individual's current and historical medical data from doctors, labs, pharmacies and other sources and augments it with evidence-based medicine to create care plans and highlight treatment opportunities.

The PCS is then delivered to the point of care through a secure Web portal to give physicians a more complete picture of a patient's medical history. This enables physicians to make faster and more informed medical decisions, which MEDecision believes can reduce waste, lower costs and facilitate better health care outcomes. It is currently being implemented for a total of 16 million people in the United States.

For more information: www.MEDecision.com

Related Content

MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...
Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...